(Q39628216)

13 September 2017

1 reference

title

Regulation of complement (English)

1 reference

13 September 2017

1

Mollnes TE

1 reference

13 September 2017

Lachmann PJ

2

1 reference

13 September 2017

publication date

1 February 1988

1 reference

Scandinavian Journal of Immunology

13 September 2017

published in

1 reference

13 September 2017

volume

27

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

127-142

1 reference

Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Hydrophilic-amphiphilic transition of the terminal SC5b-8 complement complex through tryptic modification: biochemical and ultrastructural studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Ninth component of complement: self-aggregation and interaction with lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Human genes for three complement components that regulate the activation of C3 are tightly linked

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Cellular receptors for fragments of the third component of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Properdin factor D: characterization of its active site and isolation of the precursor form

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Human C3b- and C4b-regulatory proteins: a new multi-gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

The active site of human C4a anaphylatoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Complement receptor is an inhibitor of the complement cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

C3 proactivator convertase and its mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

The alternative pathway of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

The role of antibody in the activation of the alternative complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

The proteolytic activation systems of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Human C4-binding protein. I. Isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Relationships among the complement, kinin, coagulation, and fibrinolytic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Modulation of the alternative complement pathways by beta 1 H globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

The first component of human complement (C1): Activation and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1988.TB02331.X

10.1111/J.1365-3083.1988.TB02331.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference